Our vision is that every patient should have access to the most up-to-date individualised treatments and to innovative therapies. By strengthening shared decision-making based on dynamic computer-interpretable guidelines (CIGs), innovative broad data access and AI-driven technology and tools, we envision revolutionizing oncology care in Europe.
OPTIMA is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 101034347. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The views communicated within are those of OPTIMA. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.
Company Details
- Founded
- -
- Address
- Messe Berlin
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.optima-oncology.eu
- Keywords
- Nijmegen.
Optima Oncology Questions
Optima Oncology's website is http://www.optima-oncology.eu
Optima Oncology's LinkedIn profile is https://www.linkedin.com/company/optima-oncology
Optima Oncology's industry is
Hospitals and Health Care
Optima Oncology's top competitors are
Imagio_project,
Pillai,
Explainable Ai For Molecules - Aichemist Msca Dn Horizon Europe,
Bigpicture,
Forschungscampus M²olie,
Hc:spirit,
Fairplus,
Pfizer,
Pioneer - Big Data In Prostate Cancer,
Astrazeneca.
Optima Oncology's categories are Hospitals and Health Care
Optima Oncology's founding year is 2021
